Influence of Neprilysin Inhibition on the Efficacy and Safety of Empagliflozin in Patients with Chronic Heart Failure and a Reduced Ejection Fraction: the Emperor-Reduced Trial
AuthID
P-00V-8QG
P-00V-8QG